Epigenetic Activation of μ-Opioid Receptor Gene via Increased Expression and Function of Mitogen- and Stress-Activated Protein Kinase 1

Abstract

Since the discovery of m-opioid receptor (MOR) gene two decades ago, various regulatory factors have been shown to interact with the MOR promoter and modulate transcript levels. However, the majority of early transcriptional studies on MOR gene have not addressed how intracellular signaling pathways mediate extracellular modulators. In this study, we demonstrate that MOR epigenetic regulation requires multiple coordinated signals converging at the MOR promoter, involving mitogenactivated protein kinase (MAPK) activation and mitogen-and stress-activated protein kinase 1 (MSK1)-ranges of intracellular signaling pathways similar to those activated by opioid agonists. Inhibiting p38 MAPK or extracellular signal-regulated kinase (ERK) 1/2 MAPK (upstream activators of MSK1) reduced MOR expression levels; accordingly, the functional role of MSK1, but not MSK2, was demonstrated using genetic approaches. However, for maximal MSK1 effect, an open chromatin configuration was required, because in vitro CpG methylation of the MOR promoter abolished MSK1 activity. Finally, endogenous MSK1 levels concomitantly increased to regulate MOR gene expression during neuronal differentiation of P19 cells, suggesting a conserved role of this kinase in the epigenic activation of MOR in neurons. Taken together, our findings indicate that the expression of MOR gene requires the activity of intracellular signaling pathways that have been implicated in the behavioral outcomes of opioid drugs, which suggests that an autoregulatory mechanism may function in opioid systems.

Kisspeptin modulates pain sensitivity of CFLP mice

“…Both ERK and p38 contribute to central pain sensitization via post-translational and transcriptional mechanisms [14]. As kisspeptins are potent stimulators of ERK1/2 and p38, it is plausible that they induce increased nociceptive sensitivity by affecting glutamate transmission [44], opioid [48] and/or other neuropeptide signaling [22] in the spinal cord dorsal horn neurons or upper brain regions implicated in nociceptive regulation.…”

Genome-scale Capture C promoter interactions implicate effector genes at GWAS loci for bone mineral density

“…Immunoblotting was performed using standard procedures in siRNA transfected cells 59 with minor modifications. Briefly, hMSC monolayers on 12-well plates were washed three times with ice-cold PBS, and 100 µl of lysis buffer composed of 50 mM Tris-Cl, 150 mM NaCl, 0.1% SDS, 0.1% Igepal CA 630, 0.5% sodium deoxycholate, and protease inhibitor cocktail (Roche) was added.…”

Canonical Notch signaling is required for bone morphogenetic protein-mediated human osteoblast differentiation

“…Immunoblotting was performed using standard procedures as described previously 20,21 . Briefly, hMSC monolayers were washed three times with ice‐cold PBS, and lysis buffer composed of 50 mM Tris‐Cl, 150 mM NaCl, 0.1% SDS, 0.1% Igepal CA 630, 0.5% sodium deoxycholate, and protease inhibitor cocktail (Roche) was added.…”